US Patent 8691214 Use of
Patent 8691214 was granted and assigned to Probi AB on April, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 1 Dec, 2023
Golden AI
Edits made to:
Article (+238 characters)
Article
Patent abstract
The present invention relates to the use of at least one strain of probiotic bacteria selected from Lactobacillus for the manufacture of a pharmaceutical composition for the treatment and/or prevention of a virus infection.
Edits on 5 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08691214 Use of US Patent 8691214 Use of
Infobox
Patent Number
0869121400
Patent Number
869121400
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
086912140
Date of Patent
April 8, 2014
0Patent Application Number
136191460
Date Filed
September 14, 2012
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
086912140
Date of Patent
April 8, 2014
0Patent Application Number
136191460
Date Filed
September 14, 2012
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08691214 Use of
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08691214
Date of patent
April 8, 2014
Patent application number
13619146
Date Filed
September 14, 2012
Patent primary examiner
Find more entities like US Patent 8691214 Use of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.